Peritoneal dialysis in diabetic patients

Contributions to Nephrology

Volumn 131, Issue , 2001, Pages 51-60

  Bertoli, Massimo ^a,b   Bonfante, Luciana ^a   Gambaro, Giovanni ^a   Cara, Marilena ^a   Virgilio, Bice ^a   D'Angelo, Angela ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Ospedale Giustiniani   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DIALYSIS FLUID; GLUCOSE; INSULIN;

BIOAVAILABILITY; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; METHODOLOGY; PERITONEAL DIALYSIS; PERITONITIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK; STATISTICS; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; UREMIA; VASCULAR DISEASE;

BIOLOGICAL AVAILABILITY; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIALYSIS SOLUTIONS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERTENSION; INJECTIONS, INTRAPERITONEAL; INSULIN; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; RENAL DIALYSIS; RISK; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UREMIA; VASCULAR DISEASES;

EID: 0035526683     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (56)

1. Renal Data System USRDS, Annual Data Report National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda 1998.
2. Legrain M, Rottembourg J, Bentchikou A: Dialysis treatment of insulin-dependent diabetic patients: Ten years' exeperience. Clin Nephrol 1984:21:72-77.
3. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA: Continuous ambulatory PD and hemodialysis: Comparison of patient mortality. Kidney Int 1994;45:1163-1169.
4. Blombergen WE: Comparison of continuous ambulatory PD and hemodialysis patient survival. J Am Soc Nephrol 1995;6:177-182.
5. Fenton SE, Douglas E, Snaubel MSC, Desmueles M, Morrison HI, Copleston P, Jeffery JR, Kjellstrand CM: Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997;30:334-342.
6. Keshaviah P, Ma J, Thorpe K, Churchill D, Collins A: Comparison of 2 years' survival in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995;6:540.
7. Marcelli D, Spotti D, Conte F: Survival of diabetic patients on PD or haemodialysis. Perit Dial Int 1996(suppl 16):283-287.
8. Vonesh EF, Moran J: Mortality in end-stage renal diseases: A reassessment of differences between patients treated with haemodialysis and PD. J Am Soc Nephrol 1999;10:354-365.
9. Collins AJ, Hao W, Xin H, Eblen JP, Everson SE, Costantini EG, Mo JZ: Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999;34:1065-1074.
10. Romagnoli GF, Di Landro D, Catalano C, Goepel S, Marchini F: Short-term outcome of diabetic patients in renal replacement therapy. Nephrol Dial Transplant 1998(suppl 13): 30-34.
11. Feriani M, Dell'Aquila R, La Greca G: The treatment of diabetic end-stage renal disease with PD. Nephrol Dial Transplant 1998(suppl 13):53-56.
12. Cocchi R, Esposti ED, Fabbri A, Lucatello A, Sturani A, Quarello F, Boero R, Bruno M, Dadone C, Favazza A, Scanziani R, Tommasi A, Giangrande A: Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study. Nephrol Dial Transplant 1999;14:1536-1540.
13. Chisholm L: Evolution of retinopathy in diabetics undergoing CAPD. Perit Dial Bull 1982(suppl 2): 42-47.
14. Diaz-Buxo JA: Influence of hypertension on vision in diabetics undergoing dialysis: Comparison of peritoneal and haemodialysis; in Maher F (ed): Frontiers in Peritoneal Dialysis. Manchester, 1985, pp 457-468.
15. Rottembourg J: Visual function, blood pressure and blood glucose in diabetic patients undergoing CAPD. Proc EDTA 1984;21:330-333.
16. Diaz-Buxo JA, Burgess WP, Greenman M, Chandler JT, Farmer CD, Walker PJ: Visual function in diabetic patients undergoing dialysis: Comparison of peritoneal and haemodialysis. Int J Artif Organs 1984;5:257-262.
17. Khauli RB, Noviack AC, Steinmuller DR, Buzsta C, Nakamoto S, Vidt DG, Magnusson M, Paganini E, Schreiber M: Comparison of renal transplantation and dialysis in rehabilitation of diabetic end-stage renal disease patients. Urology 1986;6:521-525.
18. Coronel F, Hostal L, Horcajo P, Narajo P, del Poro C, Torrente J, Barrientos A: Complications in diabetic patients on dialysis: Experience in 10 years of treatment using three techniques. Rev Clin Esp 1989;5:225-229.
19. Tzamaloukas AH, Yuan ZY, Balaskas E, Oreopoulos DG: CAPD in end-stage patients with renal disease due to diabetes mellitus: An update. Adv Perit Dial 1992;8:185-191.
20. Kostenbauer T, Auringen M, Irzigler K: Prevalence of cardiac autonomic neuropathies in uraemia and diabetes mellitus. Wien Klin Wochenschr 1994;106:733-737.
21. Blair GRD: Electrophysiologic studies in peripheral nerves of diabetes undergoing CAPD. Perit Dial Bull 1982(suppl 2):53-58.
22. Balaskas EV, Yuan ZY, Gupta A, Meema HE, Blair G, Bergman J, Oreopoulos DG: Long-term CAPD dialysis in diabetics. Clin Nephrol 1994;42:54-62.
23. Apostolou T, Gokal R: Neuropathy and quality of life in diabetic CAPD patients. Perit Dial Int 1999(suppl 2):242-247.
24. Hye RJ, Wolf YG: Ischemic monomelic neuropathy: An under-recognized complication of haemodialysis access. Ann Vasc Surg 1994;6:578-582.
25. Khanna R: Further experience with CAPD in diabetic with end-stage renal disease; in Keen R (ed): Diabetic Nephropathy. Grune & Stratton, New York, 1983, pp 279-285.
26. Nolph KD, Cutler SJ, Steimberg SM, Nowak JW: Special study from NIH USA: CAPD register. Perit Dial Bull 1986;6:28-35.
27. Holley J, Bernardini J, Piraini B: Catheter infections in insulin-dependent diabetics on CAPD. Perit Dial Int 1991;11:347-350.
28. Troidke LK, Gorban Brennan U, Kliger AS, Finkenstein FO: Continuous cycler therapy, manual peritoneal dialylsis therapy and peritonitis. Adv Perit Dial 1998;14:137-141.
29. Lye WC, Leong SO, van der Straaten JC, Lee EJC: A prospective study of peritoneal-related infections in CAPD patients with diabetes mellitus. Adv Perit Dial 1993;9:195-197.
30. Khanna R, Oreopulos DG: CAPD in diabetics with end-stage renal disease: A combined experience of two North American centres; in Friedman EA (ed): Diabetic Renal Retinal Syndrome. Grune & Stratton. New York, 1986, p 363.
31. Tzamaloukas AH, Murata GH, Lewis SL, Fox L, Bonner PN: Severity and complications of CAPD in diabetic and nondiabetic patients. Perit Dial Int 1993(suppl 13):236-238.
32. Schade DS, Eaton RP, Friedman NM, Spencer WJ: Normalisation of plasma insulin profiles with intra-peritoneal insulin infusion in diabetic man. Diabetologica 1980;19:35-39.
33. Scarpioni L, Ballocchi S, Castelli A, Scarpioni R: Insulin therapy in uraemic diabetic patients on CAPD: Comparison of intraperitoneal and subcutaneous administration. Perit Dial Int 1994;14: 127-131.
34. Nevalein PI, Lathela JT, Mustonen J, Taskinen MR, Pasternack A: The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD. Perit Dial Int 1999;19:148-153.
35. Bargman JM: The impact of intraperitoneal glucose and insulin on the liver. Perit Dial Int 1996(suppl 16):211-213.
36. Khanna R: PD in diabetic end-stage renal disease; in Khanna R (ed): The Textbook of Peritoneal Dialysis. Kluwer, Dordrecht, 1994, pp 639-660.
37. Nevalein PI, Lahtela JT, Mustonen J, Pasternack A: Intraperitoneal insulin reduces plasma leptin concentration in diabetic patients on CAPD. Perit Dial Int 2000;20:27-32.
38. Kolaczynski JW, Nyce MR, Considine RW, Boden G, Nolan JJ, Henry R: Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996;45:699-701.
39. Caro JF, Sinha MK, Kolaczinsky JW, Zhang PL, Considine RV: Leptin: The tale of obesity gene. Diabetes 1996;45:1455-1462.
40. Howard JK, Lord GM, Clutterbuck EJ, Chatei MA, Pusey CD, Bloom SR: Plasma immunoreactive leptin concentration in end-stage renal disease. Clin Sci 1997;93:119-126.
41. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BR: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997;51:1980-1985.
42. Scalamogna A, Castelnuovo C, Crepaldi M: Incidence of peritonitis in diabetic patients on CAPD: Intraperitoneal vs subcutaneous insulin therapy; in Khanna R (ed): Advances in CAPD. Toronto, University Press, 1987, pp 166-170.
43. Selgas R, Diez JJ, Munoz J, Miranda B, de Alvaro F, Rodriguez JC: Comparative study of two different routes for insulin administration in CAPD diabetic patients: A multicenter study. Adv Perit Dial 1989;5:181-184.
44. Wanless IR, Bargman JM, Orepoulos DG, Vas SI: Subcapsular steatonecrosis in response to peritoneal insulin delivery. Mod Pathol 1989;2:69-74.
45. Chan E, Oreopulos DG, Vas I: Administration of insulin by CAPD. Pharmacotherapy 1993;13: 455-459.
46. Vlassara H: Protein glycation in the kidney: The role in diabetes and aging. Kidney Int 1996;49: 1795-1804.
47. Friedman E: Advanced glycosylated end-products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 1999(suppl 22):65-71.
48. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Cerami A, Vlassara H: Reaction glycosylation end products in diabetic uraemia and treatment of renal failure. Lancet 1994;343:1519-1522.
49. Vlassara H: Serum advanced glycosylation end products: A new class of uraemic toxins? Blood Purif 1994;12:54-59.
50. Friedlander MA, Wu YC, Elgawish A, Monnier VM: Kinetics of formation of early and advanced glycosylation end products in PD. Clin Invest 1996;97:728-735.
51. Ho-dac-Pannekeet MM, Weiss MF, de Waart DR, Erhard P, Hiralall JK, Krediet RT: Analysis of nonenzymatic glycosylation in vivo: Impact of different dialysis solutions. Perit Dial Int 1999(suppl 19): 68-74.
52. Dawnay AB, Millar DJ: Glycation and advanced glycation end product formation with icodextrin and dextrose. Perit Dial Int 1997;17:52-58.
53. Wieslander A, Kjellstrand PT, Rippe B: Heat sterilization of glucose-containing fluids for PD: Biological consequences of chemical alterations. Perit Dial Int 1995;15:52-60.
54. Arfeen S, Goodship TH, Channon S, Ward MK: 1% amino acid peritoneal dialysate: Single-cycle study in diabetic patients with end-stage renal disease. Am J Kidney Dis 1994;23:86-90.
55. Lin JJ, Wadhawa NK, Suh H, Cabralda T, Patlak CS: Increased peritoneal solute transport in diabetic peritoneal dialysis patients; in Khanna R (ed): Advances in Peritoneal Dialysis. Toronto, Peritoneal Dialysis Publications, 1995, vol 11, pp 63-66.
56. Liberek T, Renke M, Lichodziejewska M, Rutkowski B: The role of automated PD in PD program: Once-center experience. Int J Artif Organs 1999;22:734-738.